Navigation Links
CeNeS Pharmaceuticals Plc Announces Preliminary Results for The,Year Ending 31 December 2006

Preliminary results for the year ended 31 December 2006

Product profile of lead drug candidate confirmed in large Phase III study International partnering process to commerialise M6G underway

CAMBRIDGE, England, March 28, 2007 - CeNeS Pharmaceuticals plc ("CeNeS" or "the Company"), the CNS focused developing specialty pharmaceutical company, today announces its preliminary results for the year ended 31 December 2006.

Operational Highlights

Clinical pipeline

M6G - post-operative pain

* Successful major Phase III study results announced

* showing clear benefits over morphine in management of post-operative pain * demonstrates the unique product profile

* IND submitted to FDA in March 2007 * Strengthened M6G intellectual property position * Actively pursuing M6G partnering deals

CNS 5161 - cancer pain and neuropathic pain

* Signed Revenue Sharing and Co-Development agreement with ERGOMED * PhaseI/II cancer pain study to start recruitment in mid 2007 * Second Phase II study in neuropathic pain to start later in 2007 * Phase II clinical supply manufacturing completed early 2007 * Acquisition of transdermal patch formulation IP enabling development of high value transdermal formulation for neuropathic pain

Pre-clinical/discovery pipeline

CNS 7056 - short acting sedation/anaesthesia

* Japanese, Hong Kong and European patents granted for short acting sedative * Encouraging pre-clinical studies

* reveal rapid onset and offset of sedative action and rapid metabolism * support the potential to expand the indications into anaesthesia

* Further studies in anaesthesia initiated with a large pharmaceutical company * The first CNS 7056 academic paper has been accepted for publication in "Anesthesiology" a leading journal

COMT inhibitors - Parkinson's disease

* Pre-clinical development candidate for Parkinson's
'"/>




Page: 1 2 3

Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Independent publication supports the profile of CeNeS phase II compound, CNS 5161
3. CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:8/21/2014)... Aug. 21, 2014  ACI Clinical ( www.aciclinical.com ... Data Monitoring Committees. Using this solution, ... over industry standard costs and receive the same ... in committee services. Leveraging a decade ... contracting, charter development, statistical programming and meeting facilitation), ...
(Date:8/21/2014)... PARK, N.J. , Aug. 21, 2014 /PRNewswire/ ... pharmacy group purchasing organization (GPO), is pleased to ... to collaborate on a host of innovative specialty ... help Aurora deliver enhanced therapy management services to ... Management (OTM) system. Aurora will use ...
(Date:8/21/2014)... N.Y. , Aug. 21, 2014  The board ... ), a leading provider of clinical trial imaging solutions, ... been named chief financial officer, effective immediately.  Mr. Groff ... since August 2013.  He joined VirtualScopics in January 2006 ... in February 2013. "When the board of ...
Breaking Medicine Technology:ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4
... NOVATO, Calif., Aug. 30 BioMarin Pharmaceutical Inc. (Nasdaq: ... received orphan drug designation from the U.S. Food and ... insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in ... new drug application (IND) for BMN-701 has been submitted, ...
... ROCKVILLE, Md., Aug. 30 Sequella, Inc., a ... for life-threatening infectious diseases, announced today the restatement ... University of Maryland, Baltimore (UMB), concerning certain technology ... technology patent (U.S. 6,663,846), jointly owned by Sequella ...
Cached Medicine Technology:BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease 2BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease 3Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology 2Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology 3
(Date:8/21/2014)... The Swedish-American Life Science Summit, ... focus on the Future of Medicine and the ... commercialization. , With the mission to turn new ... of business and science. "Over the years SALSS ... a diverse community with representatives challenging the boundaries ...
(Date:8/21/2014)... two types of polio vaccines seems to provide stronger ... eradicate polio, a new study shows. The research ... the Salk inactivated poliovirus vaccine (IPV) to those who ... vaccine (OPV) appeared to improve their immunity to the ... the Aug. 22 issue of the journal Science ...
(Date:8/21/2014)... Researchers have published a study examining racial and ... motor complete spinal cord injury (SCI). The article, ... and follow-up among patients with motor complete SCI," ... 2 by the Archives of Physical Medicine ... but significant differences in self-care and mobility at ...
(Date:8/21/2014)... 2014) An international scientific collaboration led by Baylor ... that may contribute to a rare form of kidney ... cancer but other types as well. , The collaboration, ... Cancer Genome Atlas initiative , completed the sequence of ... in the journal Cancer Cell . , ...
(Date:8/21/2014)... August, 21, 2014 Young girls with an intense, ... be at increased risk of developing urinary tract infections ... Medical Center. The treatment may be as simple as ... baths and swimming pools. , "Vulvitis is a common ... senior author Steve J. Hodges, M.D., associate professor of ...
Breaking Medicine News(10 mins):Health News:The Tenth Swedish-American Life Science Summit, takingplace in Stockholm, Sweden, August 20-22nd, will focus on The Future of Medicine 2Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2Health News:Researchers examine impact of race and ethnicity in motor complete spinal cord injury 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 3Health News:Researchers identify potential risk factors for urinary tract infections in young girls 2
... A new medical imager for detecting and guiding the ... spotting tumors that are half the size of the ... a new study. , The results of initial testing ... at the Department of Energys Thomas Jefferson National Accelerator ...
... Advisory Council of the National Institute of Child Health ... a Center for Reproduction and Infertility Research at the ... research aimed at expanding the science underlying the success ... improving human reproductive health. , The NICHD supports ...
... WASHINGTON, Jan. 28 The Department of,Veterans Affairs ... at its Marion, Ill., hospital. The VA today ... patient care at the Marion,facility., VA,s Inspector ... VA,s,Under Secretary for Health, on September 10, 2007 ...
... Strategy Capitalizes on Growing Trend in Professional Skin ... Beauty industry analysts at,worldwide consulting and research ... Estee Lauder to marry its powerhouse Clinique,brand with ... the cosmetics maker. The strategy will allow,Estee Lauder ...
... Humanitarian Purposes Granted to Global Vaccines, ... Jan. 28, InkSure Technologies Inc. (OTC Bulletin ... security solutions,("CMRT") for the detection of counterfeiting, ... developer of innovative authentication,and item-level identification technologies, ...
... Members, Appoints New CEO -, BALTIMORE, Jan. ... the healthcare of chronically ill seniors, today,announced that ... to the company,s nine-person board. The modified board ... executive officer and,chairman of the board., Patrick ...
Cached Medicine News:Health News:Device zeroes in on small breast tumors 2Health News:National Institutes of Health funds new center for reproduction and infertility research at Illinois 2Health News:VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 2Health News:VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 3Health News:VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 4Health News:Kline Analysts Say Clinique-Allergan Deal Sets Beauty Industry Precedent in Channel Diversification 2Health News:Kline Analysts Say Clinique-Allergan Deal Sets Beauty Industry Precedent in Channel Diversification 3Health News:InkSure and AuthentiForm Announce Assignment of Patent Portfolio 2Health News:InkSure and AuthentiForm Announce Assignment of Patent Portfolio 3Health News:XLHealth Corporation Announces Executive Changes 2
... therapeutic, expandable turning surface for the BariMaxx™ ... Prevention and treatment of pressure ulcers, Large ... patients using a statuc mattress that would ... whose body weight and size pose a ...
... healthcare bed system which helps provide comfort ... care setting, ,INDICATIONS: ,Patients weighing up ... ,Healthcare frame accommodating one or two ... ,CONTRAINDICATIONS: ,Total weight in excess of 600 ...
... flexible environment for patient care, paired with ... support, treatment and prevention., ,INDICATIONS: ,Large ... patients at risk for pressure ulcers ,Any ... would benefit from a pressure reduction surface ...
... Rest Deluxe Transport beds feature folding head end and ... storage. With the head end and foot end deck ... reduced to approximately 67". This compact length makes storage, ... ,This feature is not available on Model 4748B, ...
Medicine Products: